Avantor (AVTR) Stock Forecast & Price Target

$25.59

+2.77 (+12.14%)

(As of 07/26/2024 ET)

Avantor - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 16 Analyst Ratings

Based on 16 Wall Street analysts who have issued ratings for Avantor in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 5 have given a hold rating, and 11 have given a buy rating for AVTR.

Consensus Price Target

$25.93
1.32% Upside

High Forecast	$31.00
Average Forecast	$25.93
Low Forecast	$22.00

According to the 16 analysts' twelve-month price targets for Avantor, the average price target is $25.93. The highest price target for AVTR is $31.00, while the lowest price target for AVTR is $22.00. The average price target represents a forecasted upside of 1.32% from the current price of $25.59.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	11 Buy rating(s)	12 Buy rating(s)	12 Buy rating(s)	9 Buy rating(s)
Hold	5 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$25.93	$26.71	$26.71	$28.65
Forecasted Upside	1.32% Upside	16.60% Upside	16.37% Upside	32.76% Upside

Get Avantor Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AVTR and its competitors with MarketBeat's FREE daily newsletter.

Ad Unstoppable Prosperity

“Generational Bull Run” Incoming

LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.

You can find out what they are by clicking here now.

AVTR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

AVTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Avantor Stock vs. The Competition

Type	Avantor	Medical Companies	S&P 500
Consensus Rating Score	2.69	2.72	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	1.32% Upside	2,864.75% Upside	9.14% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
7/15/2024	Royal Bank of Canada 4 of 5 stars		Boost Target	Outperform ➝ Outperform	$30.00 ➝ $31.00	+47.97%
7/10/2024	Citigroup 3 of 5 stars	P. Donnelly Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$30.00 ➝ $23.00	+10.13%
7/2/2024	Evercore ISI 2 of 5 stars		Lower Target	Outperform ➝ Outperform	$28.00 ➝ $27.00	+30.88%
6/28/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$28.00 ➝ $25.00	+17.26%
4/29/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$27.00 ➝ $26.00	+8.60%
4/18/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$23.00 ➝ $25.00	+2.54%
Get the Latest News and Ratings for AVTR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.
2/15/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$25.00 ➝ $29.00	+18.13%
2/15/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$26.00 ➝ $29.00	+18.08%
1/26/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$22.50 ➝ $26.00	+18.51%
12/13/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Peer Perform
12/11/2023	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$21.00 ➝ $28.00	+33.46%
12/7/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$23.00 ➝ $26.00	+23.99%
10/30/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$24.00 ➝ $22.00	+29.03%
9/28/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Market Perform	$22.00	+5.90%
7/31/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Larew Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
7/30/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	$27.00 ➝ $24.00	+12.78%
5/1/2023	888 Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Maintains
2/8/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight	$25.00 ➝ $28.00	+17.60%
11/1/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$26.00	+30.13%
10/31/2022	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral	$32.00 ➝ $25.00	+30.07%
9/19/2022	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$35.00 ➝ $28.00	+24.56%
9/15/2022	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight	$51.00 ➝ $40.00	+70.50%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:13 AM ET.

AVTR Forecast - Frequently Asked Questions

What is Avantor's forecast for 2024?: According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Avantor is $25.93, with a high forecast of $31.00 and a low forecast of $22.00.
Should I buy or sell Avantor stock right now?: 16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last twelve months. There are currently 5 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" AVTR shares.
Does Avantor's stock price have much upside?: According to analysts, Avantor's stock has a predicted upside of 19.33% based on their 12-month stock forecasts.
Has Avantor been downgraded by Wall Street analysts recently?: Over the previous 90 days, Avantor's stock had 1 downgrade by analysts.
What analysts cover Avantor?: Avantor has been rated by research analysts at Barclays, Citigroup, Evercore ISI, Robert W. Baird, and Royal Bank of Canada in the past 90 days.
Do Wall Street analysts like Avantor more than its competitors?: Analysts like Avantor less than other "medical" companies. The consensus rating score for Avantor is 2.69 while the average consensus rating score for "medical" companies is 2.72. Learn more on how AVTR compares to other companies.